TP53 and neuroblastoma: In a vast number of genome-wide association studies (GWASs), it has been investigated that many SNPs are associated with the incidence of neuroblastoma or the success of therapy, such as genetic variants in LIN28B, AXIN2, LMO1, BARD1, CDK1NB, CASC15, SMARCA4, CHEK2, BRCA1, and TP53 (16–19).